Published in J Crohns Colitis on September 25, 2011
Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther (2013) 2.06
Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis. Inflamm Bowel Dis (2015) 1.06
The vitamin D status in inflammatory bowel disease. PLoS One (2014) 0.88
Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission. Dig Dis Sci (2015) 0.83
Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. World J Gastroenterol (2014) 0.83
Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.82
Association of Vitamin D Status and Clinical Outcome in Dogs with a Chronic Enteropathy. J Vet Intern Med (2015) 0.78
Vitamin d and inflammatory bowel disease. Biomed Res Int (2015) 0.76
Manipulating bone disease in inflammatory bowel disease patients. Ann Gastroenterol (2013) 0.76
Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease. World J Gastroenterol (2014) 0.75
The Role of Vitamin D in Inflammatory Bowel Disease. Healthcare (Basel) (2015) 0.75
Vitamin D status in Inflammatory Bowel Disease: Are clinicians seeing the light? J Crohns Colitis (2012) 0.75
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. PLoS One (2017) 0.75
Determination of Vitamin D Serum Levels and Status of the C3435T Polymorphism of Multidrug Resistance 1 Gene in Southeastern Iranian Patients with Ulcerative Colitis. Middle East J Dig Dis (2015) 0.75
Impact of vitamin D on the hospitalization rate of Crohn's disease patients seen at a tertiary care center. World J Gastroenterol (2017) 0.75
Postprandial response of bone turnover markers in patients with Crohn's disease. World J Gastroenterol (2014) 0.75
Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet (2008) 7.63
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet (2010) 3.22
Geographical variability and environmental risk factors in inflammatory bowel disease. Gut (2013) 1.84
Argon plasma coagulation as first-line treatment for chronic radiation proctopathy. J Gastroenterol Hepatol (2004) 1.72
Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol (2006) 1.66
Dietary antigens in Crohn's disease: antibodies to porcine pancreatic amylase. Am J Gastroenterol (2007) 1.44
The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology (2006) 1.39
Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet (2003) 1.30
E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut (2010) 1.22
Seasonal variation of serum vitamin D and the effect of vitamin D supplementation in Irish community-dwelling older people. Age Ageing (2010) 1.17
Treatment of Helicobacter pylori. Helicobacter (2005) 1.16
The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflamm Bowel Dis (2007) 1.13
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol Suppl (2006) 1.12
Treatment of Helicobacter pylori infection. Helicobacter (2008) 1.02
Treatment of Helicobacter pylori infection 2012. Helicobacter (2012) 1.02
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course. Scand J Gastroenterol (2007) 1.00
Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients. Aliment Pharmacol Ther (2005) 1.00
Treatment of Helicobacter pylori infection 2010. Helicobacter (2010) 1.00
Treatment of Helicobacter pylori infection. Helicobacter (2003) 0.99
Treatment of Helicobacter pylori infection 2011. Helicobacter (2011) 0.97
Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol (2006) 0.97
Treatment of Helicobacter pylori infection 2013. Helicobacter (2013) 0.96
Association of gastric disease with polymorphisms in the inflammatory-related genes IL-1B, IL-1RN, IL-10, TNF and TLR4. Eur J Gastroenterol Hepatol (2009) 0.95
IBD patients need in health quality of care ECCO consensus. J Crohns Colitis (2008) 0.92
Nutritional Therapy in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol (2004) 0.91
Improving compliance with helicobacter pylori eradication therapy: when and how? Therap Adv Gastroenterol (2009) 0.91
Treatment of Helicobacter pylori infection. Helicobacter (2006) 0.89
Patients with chronic pancreatitis are at increased risk for osteoporosis. Pancreas (2012) 0.89
Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease. Inflamm Bowel Dis (2007) 0.89
High prevalence of overweight and obesity in adults with Crohn's disease: associations with disease and lifestyle factors. J Crohns Colitis (2012) 0.89
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort. Inflamm Bowel Dis (2014) 0.87
Treatment of Helicobacter pylori infection. Helicobacter (2009) 0.87
Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates. World J Gastroenterol (2005) 0.86
Identification of a new segment involved in cagA 3' region variation of Helicobacter pylori. FEMS Immunol Med Microbiol (2002) 0.86
Isolated active ileitis: is it a mild subtype of Crohn's disease? Inflamm Bowel Dis (2013) 0.85
Practical treatment of Helicobacter pylori: a balanced view in changing times. Eur J Gastroenterol Hepatol (2014) 0.85
Therapy of Helicobacter pylori. Helicobacter (2004) 0.85
Treatment of Helicobacter pylori infection 2014. Helicobacter (2014) 0.84
Effectiveness of antiinfectives. Chemotherapy (2005) 0.84
Adherence to colorectal polyp surveillance guidelines: is there a 'scope' to increase the opportunities for screening? Eur J Cancer Prev (2011) 0.83
Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission. Dig Dis Sci (2015) 0.83
Nutritional Treatments in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol (2001) 0.83
Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classification. J Crohns Colitis (2007) 0.82
Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort. Eur J Gastroenterol Hepatol (2014) 0.82
Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease. Scand J Gastroenterol (2007) 0.81
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II. J Crohns Colitis (2009) 0.81
Vitamin D status and cytokine levels in patients with Crohn's disease. Int J Vitam Nutr Res (2011) 0.80
Vitamin D depletion: of clinical significance in advanced cancer? Support Care Cancer (2011) 0.80
The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis. Nutr Clin Pract (2014) 0.80
Primary prevention of colorectal cancer: are we closer to reality? Eur J Gastroenterol Hepatol (2010) 0.80
Screening for colorectal cancer: what fits best? Expert Rev Gastroenterol Hepatol (2012) 0.80
A genetic locus of Helicobacter pylori inversely associated with gastric intestinal metaplasia. FEMS Immunol Med Microbiol (2005) 0.80
An Association between MicroRNA-21 Expression and Vitamin D Deficiency in Coronary Artery Disease. Microrna (2015) 0.79
Nutrition treatment of deficiency and malnutrition in chronic pancreatitis: a review. Nutr Clin Pract (2010) 0.79
A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population. Eur J Gastroenterol Hepatol (2015) 0.78
Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test. Eur J Gastroenterol Hepatol (2014) 0.78
Safety of infliximab in 10 years of clinical practice. Eur J Gastroenterol Hepatol (2011) 0.78
Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland. Eur J Gastroenterol Hepatol (2010) 0.78
Vitamin D and orthostatic hypotension. Age Ageing (2012) 0.78
Vitamin D: new roles and therapeutic potential in inflammatory bowel disease. Curr Drug Metab (2012) 0.78
The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population. Eur J Gastroenterol Hepatol (2013) 0.77
Pretreatment antimicrobial susceptibility testing is not cost saving in the standard eradication of Helicobacter pylori. Clin Gastroenterol Hepatol (2004) 0.76
Gastric retention and wireless capsule endoscopy in adults: a modified technique for direct duodenal deployment. Gut (2010) 0.75
Food Intolerance: Dietary Treatments in Functional Bowel Disorders. Curr Treat Options Gastroenterol (2003) 0.75
Improving surveillance for Barrett's oesophagus: better to be looked over than be overlooked. BMJ (2006) 0.75
Re: Herrlinger et al.--Pulmonary function abnormalities in inflammatory bowel disease. Am J Gastroenterol (2002) 0.75
Reply to Dr. Yamamoto et al.'s letter. J Crohns Colitis (2012) 0.75
Risk factors for cardiovascular events in inflammatory bowel disease. Am J Gastroenterol (2011) 0.75
Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum. Gut (2010) 0.75
Evaluation of 6 candidate genes on chromosome 11q23 for coeliac disease susceptibility: a case control study. BMC Med Genet (2010) 0.75
Lower Cathelicidin Concentrations In Irish Athletes Compared To Healthy Controls: A Role For Vitamin D?: 1310 June 2, 9: 00 AM - 9: 15 AM. Med Sci Sports Exerc (2016) 0.75
The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. Eur J Gastroenterol Hepatol (2017) 0.75
Can individuals who are specialists in death, dying, and bereavement contribute to the prevention and/or mitigation of armed conflicts and cycles of violence? Death Stud (2014) 0.75
Altered cardia epithelial cell kinetics induced by Helicobacter pylori infection and gastro-oesophageal reflux disease: possible malignant potential? Eur J Gastroenterol Hepatol (2003) 0.75
The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. Eur J Gastroenterol Hepatol (2017) 0.75
Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease. Dig Dis Sci (2015) 0.75
A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients. Eur J Gastroenterol Hepatol (2016) 0.75
Introduction from the president. United European Gastroenterol J (2013) 0.75
Research on digestive and liver diseases: a priority for Europe - the societal importance of gastrointestinal diseases and research. Eur J Gastroenterol Hepatol (2013) 0.75
Innovations in gastro-intestinal endoscopy: endoscopic antireflux therapies for gastro-oesophageal reflux disease. Dig Dis (2002) 0.75